Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
25.34
-0.17 (-0.67%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Nurix Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Cash & Equivalents | 720.24 | 246.96 | 110 | 54.63 | 64.47 | 80.51 |
Short-Term Investments | 328.01 | 345.98 | 499.59 | 233.28 | 244.67 | 215.21 |
Cash & Short-Term Investments | 1,048 | 592.94 | 609.58 | 287.91 | 309.14 | 295.72 |
Cash Growth | 144.45% | -2.73% | 111.73% | -6.87% | 4.54% | 5.18% |
Accounts Receivable | 20 | - | - | - | - | 6 |
Other Receivables | 2.8 | 1.5 | 1.5 | 0.8 | 1.1 | 1.1 |
Receivables | 22.8 | 1.5 | 1.5 | 0.8 | 1.1 | 7.1 |
Prepaid Expenses | 32.64 | 12.38 | 8.3 | 6.8 | 8.21 | 8.29 |
Total Current Assets | 1,104 | 606.82 | 619.39 | 295.5 | 318.45 | 311.12 |
Property, Plant & Equipment | 68.04 | 73.01 | 45.9 | 47.95 | 29.51 | 25.35 |
Long-Term Investments | 14.83 | - | - | 7.42 | 63.88 | 137.19 |
Long-Term Deferred Charges | - | 0.1 | 0.1 | 0.5 | 0.5 | 0.5 |
Other Long-Term Assets | 8.74 | 8.21 | 3.96 | 4.22 | 4.42 | 2.62 |
Total Assets | 1,195 | 688.14 | 669.34 | 355.6 | 416.76 | 476.77 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Accounts Payable | 32.98 | 11.22 | 11.48 | 6.4 | 5.06 | 6.65 |
Accrued Expenses | 48.24 | 51.7 | 34.48 | 24.19 | 20.84 | 13.82 |
Current Portion of Leases | 3.24 | 2.82 | 8.01 | 7.49 | 5.53 | 3.85 |
Current Income Taxes Payable | 13.95 | 1.06 | 1.24 | 0.03 | 0.09 | 0.08 |
Current Unearned Revenue | 8.61 | 17.58 | 38.36 | 48.1 | 37.63 | 41.21 |
Other Current Liabilities | 23.72 | 2.1 | 2.28 | 0.75 | 1.5 | 0.66 |
Total Current Liabilities | 130.74 | 86.47 | 95.85 | 86.96 | 70.66 | 66.26 |
Long-Term Leases | 62.09 | 52.91 | 20.29 | 23.13 | 6.43 | 9.19 |
Long-Term Unearned Revenue | 10.78 | 10.01 | 26.21 | 45.02 | 35.97 | 59.02 |
Other Long-Term Liabilities | 23.38 | - | - | - | - | - |
Total Liabilities | 226.99 | 149.39 | 142.35 | 155.11 | 113.06 | 134.47 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Common Stock | 0.11 | 0.1 | 0.08 | 0.05 | 0.05 | 0.05 |
Additional Paid-In Capital | 1,599 | 1,542 | 1,266 | 746.3 | 709.22 | 563.76 |
Retained Earnings | -630.13 | -1,003 | -738.77 | -545.2 | -401.25 | -220.89 |
Comprehensive Income & Other | -0.21 | 0.11 | 0.15 | -0.66 | -4.32 | -0.61 |
Total Common Equity | 968.31 | 538.75 | 526.99 | 200.49 | 303.7 | 342.3 |
Shareholders' Equity | 968.31 | 538.75 | 526.99 | 200.49 | 303.7 | 342.3 |
Total Liabilities & Equity | 1,195 | 688.14 | 669.34 | 355.6 | 416.76 | 476.77 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Total Debt | 65.33 | 55.73 | 28.3 | 30.61 | 11.96 | 13.04 |
Net Cash (Debt) | 982.92 | 537.21 | 581.28 | 264.72 | 361.06 | 419.87 |
Net Cash Growth | 163.98% | -7.58% | 119.59% | -26.68% | -14.01% | 49.34% |
Net Cash Per Share | 8.97 | 6.20 | 8.66 | 4.87 | 7.43 | 9.79 |
Filing Date Shares Outstanding | 109.25 | 102.84 | 75.89 | 48.89 | 47.27 | 44.74 |
Total Common Shares Outstanding | 109.2 | 101.81 | 75.87 | 48.72 | 47.17 | 44.66 |
Working Capital | 972.95 | 520.35 | 523.53 | 208.55 | 247.79 | 244.86 |
Book Value Per Share | 8.87 | 5.29 | 6.95 | 4.12 | 6.44 | 7.66 |
Tangible Book Value | 968.31 | 538.75 | 526.99 | 200.49 | 303.7 | 342.3 |
Tangible Book Value Per Share | 8.87 | 5.29 | 6.95 | 4.12 | 6.44 | 7.66 |
Machinery | 45.85 | 44.75 | 41.04 | 33.83 | 27.62 | 19.3 |
Leasehold Improvements | 10.86 | 9.37 | 5.14 | 3.24 | 3.83 | 3.08 |